Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (926) Arrow Down
Filter Results: (926) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (926)
    • People  (2)
    • News  (70)
    • Research  (778)
    • Events  (1)
    • Multimedia  (2)
  • Faculty Publications  (668)

Show Results For

  • All HBS Web  (926)
    • People  (2)
    • News  (70)
    • Research  (778)
    • Events  (1)
    • Multimedia  (2)
  • Faculty Publications  (668)
← Page 30 of 926 Results →
  • April 2010
  • Teaching Note

Global Talent Management at Novartis (TN)

By: Jordan I. Siegel
Teaching Note for 708486. View Details
Keywords: Performance Evaluation; Talent and Talent Management; System; Multinational Firms and Management; Motivation and Incentives; Developing Countries and Economies; Pharmaceutical Industry; China
Citation
Purchase
Related
Siegel, Jordan I. "Global Talent Management at Novartis (TN)." Harvard Business School Teaching Note 710-482, April 2010.
  • December 2007 (Revised January 2008)
  • Teaching Note

Eli Lilly: Developing Cymbalta (TN)

By: Elie Ofek
Teaching Note for 507-044 View Details
Keywords: Health; Pharmaceutical Industry
Citation
Purchase
Related
Ofek, Elie. "Eli Lilly: Developing Cymbalta (TN)." Harvard Business School Teaching Note 508-061, December 2007. (Revised January 2008.)
  • April 1989 (Revised May 1993)
  • Case

Novel Combination of Two Drugs (A)

By: Regina E. Herzlinger
Keywords: Health; Health Care and Treatment; Pharmaceutical Industry
Citation
Find at Harvard
Related
Herzlinger, Regina E. "Novel Combination of Two Drugs (A)." Harvard Business School Case 189-168, April 1989. (Revised May 1993.)
  • April 1989 (Revised July 1992)
  • Supplement

Technology Transfer: Anti-Inflammatory Drug (C)

By: Regina E. Herzlinger
Keywords: Health; Pharmaceutical Industry
Citation
Find at Harvard
Related
Herzlinger, Regina E. "Technology Transfer: Anti-Inflammatory Drug (C)." Harvard Business School Supplement 189-167, April 1989. (Revised July 1992.)
  • May 2005
  • Supplement

GlaxoSmithKline: Reorganizing Drug Discovery (B)

By: Robert S. Huckman and Eli Strick
Supplements the (A) case. View Details
Keywords: Mergers and Acquisitions; Decisions; Operations; Performance; Research and Development; Restructuring; Organizations; Pharmaceutical Industry
Citation
Purchase
Related
Huckman, Robert S., and Eli Strick. "GlaxoSmithKline: Reorganizing Drug Discovery (B)." Harvard Business School Supplement 605-075, May 2005.
  • August 2004 (Revised July 2006)
  • Case

PROPECIA TM: Helping Make Hair Loss History

By: Marta Wosinska and Youngme E. Moon
In late 1997, Tom Casola, brand manager for Propecia, debates the best approach to market this breakthrough one-a-day pill for hair loss. This launch would be atypical for a prescription drug because of the key position of the consumer. As a result, the team's... View Details
Keywords: Advertising; Communication Strategy; Customers; Marketing Communications; Marketing Strategy; Product Launch; Product; Performance Effectiveness; Problems and Challenges; Quality; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Wosinska, Marta, and Youngme E. Moon. "PROPECIA TM: Helping Make Hair Loss History." Harvard Business School Case 505-035, August 2004. (Revised July 2006.)
  • July 2004 (Revised February 2005)
  • Teaching Note

Marketing Antidepressants: Prozac and Paxil (TN)

By: Youngme E. Moon
Teaching Note to (9-502-055). View Details
Keywords: Marketing; Pharmaceutical Industry
Citation
Purchase
Related
Moon, Youngme E. "Marketing Antidepressants: Prozac and Paxil (TN)." Harvard Business School Teaching Note 505-009, July 2004. (Revised February 2005.)
  • March 2001 (Revised September 2002)
  • Case

Merck Latin America (D): Mexico

By: Michael Beer and James Weber
Examines Merck's change effort in Mexico from the perspective of the local employees. View Details
Keywords: Change Management; Cross-Cultural and Cross-Border Issues; Multinational Firms and Management; Employees; Operations; Perspective; Pharmaceutical Industry; Mexico
Citation
Educators
Purchase
Related
Beer, Michael, and James Weber. "Merck Latin America (D): Mexico." Harvard Business School Case 401-032, March 2001. (Revised September 2002.)
  • March 2001 (Revised September 2002)
  • Case

Merck Latin America (A)

By: Michael Beer and James Weber
Introduces Grey Warner, the vice president of Merck's Latin America region, and his efforts to improve the organizational effectiveness of the region and to introduce a more global business culture and values. Discusses Merck's ethics and values, its Latin American... View Details
Keywords: Organizational Culture; Ethics; Business Processes; Strategic Planning; Change Management; Values and Beliefs; Globalized Firms and Management; Employee Relationship Management; Business Strategy; Government and Politics; Economy; Pharmaceutical Industry; Latin America
Citation
Educators
Purchase
Related
Beer, Michael, and James Weber. "Merck Latin America (A)." Harvard Business School Case 401-029, March 2001. (Revised September 2002.)
  • February 2000 (Revised June 2003)
  • Case

Pepcid AC: Racing to the OTC Market

By: Charles King III, Alvin J. Silk, Ernst R. Berndt and Lisa R. Klein
Pepcid management must decide whether to risk all in a race to be first in the over-the-counter market with a new heartburn remedy. View Details
Keywords: Competitive Advantage; Product Positioning; Markets; Research; Marketing Strategy; Product Development; Decision Choices and Conditions; Pharmaceutical Industry
Citation
Educators
Purchase
Related
King, Charles, III, Alvin J. Silk, Ernst R. Berndt, and Lisa R. Klein. "Pepcid AC: Racing to the OTC Market." Harvard Business School Case 500-073, February 2000. (Revised June 2003.)
  • June 1999 (Revised October 1999)
  • Case

Eli Lilly, 1998 (B): Emerging Global Organization

By: Michael Y. Yoshino and Thomas W. Malnight
Examines major issues faced by Eli Lilly as it evaluates the appropriateness of a focused matrix organization with extensive use of cross-functional teams. View Details
Keywords: Business Model; Geography; Globalized Firms and Management; Growth and Development; Knowledge; Management Teams; Product; Organizations; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Yoshino, Michael Y., and Thomas W. Malnight. "Eli Lilly, 1998 (B): Emerging Global Organization." Harvard Business School Case 399-174, June 1999. (Revised October 1999.)
  • October 1987 (Revised November 1994)
  • Case

Boston Fights Drugs (A): Designing Communications Research

By: V. Kasturi Rangan
Describes in detail the research mounted by five individuals with a $20,000 budget to combat drug abuse among Boston's school-going population. Using the focus group methodology they discover that most of the current anti-drug advertising is useless. They create their... View Details
Keywords: Budgets and Budgeting; Misleading and Fraudulent Advertising; Communication Intention and Meaning; Brands and Branding; Performance Evaluation; Research and Development; Segmentation; Pharmaceutical Industry; Boston
Citation
Educators
Purchase
Related
Rangan, V. Kasturi. "Boston Fights Drugs (A): Designing Communications Research." Harvard Business School Case 588-031, October 1987. (Revised November 1994.)
  • September 1983 (Revised October 1984)
  • Case

Syntex Laboratories (A)

A consulting project involving a mathematical model of the sales force indicates that Syntex Labs should nearly double the size of their sales force and drastically alter their allocation of sales effort to the product line and physician specialties. The questions are... View Details
Keywords: Organizational Change and Adaptation; Strategic Planning; Salesforce Management; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Clarke, Darral G. "Syntex Laboratories (A)." Harvard Business School Case 584-033, September 1983. (Revised October 1984.)
  • March 1980 (Revised February 1984)
  • Case

Kramer Pharmaceuticals, Inc.

The 12-year career of Mr. Bob Marsh is traced, from recruitment to termination. Data on Kramer's sales management, performance evaluation, compensation, and sales training systems are given. View Details
Keywords: Personal Development and Career; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Newton, Derek A. "Kramer Pharmaceuticals, Inc." Harvard Business School Case 580-125, March 1980. (Revised February 1984.)
  • 01 Jan 2008
  • News

Jeffrey R. Immelt, MBA 1982

Jeff Immelt’s night table—Railway Age, Aviation Week, Broadcasting & Cable—represents just a few of the industries encompassed by General Electric, the company founded by Thomas Edison where Immelt is entering his ninth year as chairman... View Details
  • 01 Aug 2001
  • News

Cleveland Global Alumni Conference a Sold-Out Success

& Co., kicked off the first plenary session with a quick overview of factors contributing to the U.S. pharmaceutical industry's success in competing in the global market. Among other ad- vantages, Gilmartin cited the U.S. government's... View Details
Keywords: Hanna, Julia; Frank Batten (MBA '52); Colleges, Universities, and Professional Schools; Educational Services
  • 23 May 2000
  • Research & Ideas

Minding the Muse: The Impact of Downsizing on Corporate Creativity

pharmaceutical firms that rely on creativity," she says. "Today's fast-changing global markets place increased pressure on companies of every kind to continuously create new products, services, and competitive strategies if they... View Details
Keywords: by Peter K. Jacobs
  • 18 Aug 2017
  • Op-Ed

Op-Ed: Courageous Leader Triggers a Moral Revolt of CEOs Against Trump

actions was not without risk for the CEOs and their companies” While many CEOs prefer to stay under the radar and avoid public scrutiny, Ken Frazier led the way with his example. As the chair of PhRMA, the pharmaceutical manufacturers... View Details
Keywords: by Bill George
  • 01 Mar 2012
  • News

How to Close the Health Gap

real progress has been made over the last decade, thanks in part to funding from organizations such as the Bill & Melinda Gates Foundation and efforts by pharmaceutical companies and governments to make drugs available at little or no... View Details
Keywords: Sean Silverthorne; Publishing Industries (except Internet); Publishing Industries (except Internet); Publishing Industries (except Internet); Publishing Industries (except Internet)
  • 13 Oct 2016
  • News

Adding Muscle to the Fight Against Disease

portfolio of programs in parallel.” In an industry where serial entrepreneurship is the norm, Cytokinetics’s approach instead requires “a strategy based on sustainability and durability” that includes forging significant partnerships with... View Details
Keywords: Deborah Blagg
  • ←
  • 30
  • 31
  • …
  • 46
  • 47
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.